Cited by 137Substance Abuse Treatment and OutcomesForensic Toxicology and Drug AnalysisPsychedelics and Drug Studies

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

The Nonmedical Use of Ketamlne, Part Two: A Review of Problent Use and Dependence

Jansen, Karl L.R., Darracot-Cankovic, Rachael·2001·Journal of Psychoactive Drugs

DOI 10.1080/02791072.2001.10400480

Open this paper in CoChat — free account

Abstract

This is the second part of a review of the nonmedical use of ketamine. Part one discussed the history of ketamine, the sought-after effects for which it is taken in a nonmedical context, how these are produced, common adverse effects, the ketamine schizophrenia model and the neurotoxicity issue. Part two reviews what is currently known about problem use of ketamine, ketamine dependence, treatment options and harm minimization issues. Some ketamine users become dependent on the drug in a manner resembling cocaine dependence, with craving and a high tolerance but no evidence of a physiological withdrawal syndrome. The likely mechanisms of this dependence are discussed in terms of what is known about the neurochemistry of ketamine, its psychological effects, and published case histories in both the formal and informal literature. The conclusions are that ketamine dependence is linked with effects that this complex drug has in common with not only cocaine and amphetamine but also with opiates, alcohol and cannabis, as well as the psychological attractions of its distinctive psychedelic properties.

Integrity signals

Registry

Crossref · 10.1080/02791072.2001.10400480

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Lindemann, L., Jaeschke, G., Michalon, A., Vieira, E., Honer, M., Spooren, W., Porter, R., Hartung, T., Kolczewski, S., Büttelmann, B., et al. (1909) · JAMA · doi:10.1001/jama.1909.02550020033007 · Cited by 7,889
The varieties of religious experience: A study in human nature.
James, W. (1902) · doi:10.1037/10004-000 · Cited by 5,204
Untitled work
(1991) · Medical Entomology and Zoology · Cited by 4,438
The American Journal of Psychiatry
(2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp · Cited by 2,616
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Psychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857
Ketamine Psychedelic Therapy (KPT): A Review of the Results of Ten Years of Research
Krupitsky, E. M., & Grinenko, A. Y. (1997) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1997.10400185 · Cited by 246
A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences
Jansen, K. L. R. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10400244 · Cited by 229
Self-citation
Circulatory Responses to Ketamine Anesthesia
Tweed, W. A., Minuck, M., & Mymin, D. (1972) · Anesthesiology · doi:10.1097/00000542-197212000-00008 · Cited by 210
The Effects of NMDA Receptor Antagonists and Nitric Oxide Synthase Inhibitors on Opioid Tolerance and Withdrawal Medication Development Issues for Opiate Addiction
Herman, B. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00140-9 · Cited by 196

Show all 51 references

Research works printed but not linked: 10

Grof S., 1988, The Adventure of Self-Discovery—Dimensions of Consciousness and New Perspectives in Psychotherapy and Inner Exploration.
Hall C. H., 1992, The Independent, 5
10.1023/A:1025055109480 · DOI
McCarthy D. A., 1976, Anaesthesiology, 399, 160
Mills H., 1996, The Observer, 10
Moore M., 1978, Journeys into the Bright World.
Siegel R. K., 1978, Phencyclidine Abuse: An Appraisal.
Sputz R., 1989, High Times, 64
Turner D. M., 1994, The Essential Guide to Psychedelics.
1992, The ICD-10 Classification of Mental and Behavioural Disorders.

Sorted by citations

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
Contribution of CYP3A4, CYP2B6, and CYP2C9 Isoforms to N-Demethylation of Ketamine in Human Liver Microsomes
Hijazi, Y., & Boulieu, R. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.7.853 · Cited by 287
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Ketamine abuse potential and use disorder
Liu, Y., Lin, D., Wu, B., & Zhou, W. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.05.016 · Cited by 256
The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use
Kalsi, S. S., Wood, D. M., & Dargan, P. I. (2011) · Emerging Health Threats Journal · doi:10.3402/ehtj.v4i0.7107 · Cited by 235
Cannabinoids in health and disease
Kogan, N. M., & Mechoulam, R. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.4/nkogan · Cited by 227
Ketamine
Wolff, K., & WINSTOCK, A. R. (2006) · CNS Drugs · doi:10.2165/00023210-200620030-00003 · Cited by 214
Metabolism and metabolomics of ketamine: a toxicological approach
Dinis‐Oliveira, R. J. (2017) · Forensic Sciences Research · doi:10.1080/20961790.2017.1285219 · Cited by 179
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Party Drugs: Properties, Prevalence, Patterns, and Problems
Maxwell, J. C. (2005) · Substance Use & Misuse · doi:10.1081/ja-200066736 · Cited by 140
Club Drugs and HIV Infection: A Review
Mayer, K. H., Colfax, G. N., & Guzman, R. (2006) · Clinical Infectious Diseases · doi:10.1086/503259 · Cited by 142
Recognition and management of complications of new recreational drug use
Ricaurte, G. A., & McCann, U. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66737-2 · Cited by 134
Synaptic Plasticity, Metaplasticity and Depression
Vose, L. R., & Stanton, P. K. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160202121111 · Cited by 131
Ketamine applications beyond anesthesia – A literature review
Nowacka, A., & Borczyk, M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172547 · Cited by 129
Ketamine associated psychedelic effects and dependence.
Dk, L. (2003) · PubMed · Cited by 96
Ketamine: A Controversial Drug for Neonates
Bhutta, A. T. (2007) · Seminars in Perinatology · doi:10.1053/j.semperi.2007.07.005 · Cited by 96
Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine’s Antidepressant Response and the Development of Ketamine Addiction
Bonnet, U. (2015) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2015.1072653 · Cited by 91
Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development
Lerner, A., & Klein, M. (2019) · Brain Communications · doi:10.1093/braincomms/fcz025 · Cited by 89
Gender differences in subjective discontinuation symptoms associated with ketamine use
Chen, W.-Y., Huang, M.-C., & Lin, S.-K. (2014) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/1747-597x-9-39 · Cited by 87
“Ketamine has not been a major drug of abuse within the past two decades, and only a few cases have been reported during this time [10,11].”
Background
The Effects of Ketamine Vary Among Inbred Mouse Strains and Mimic Schizophrenia for the P80, but not P20 or N40 Auditory ERP Components
Connolly, P. M., Maxwell, C. R., Liang, Y., Kahn, J. B., Kanes, S., Abel, T. G., Gur, R. E., Turetsky, B. I., & Siegel, S. J. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023605.68408.fb · Cited by 84
Acute Toxic Effects of Club Drugs
Gable, R. S. (2004) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2004.10400031 · Cited by 81
A case of ketamine dependence with discontinuation symptoms
Critchlow, D. G. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01494.x · Cited by 79
Medication and Substance Abuse
Gillin, J. C., Drummond, S. P. A., Clark, C. P., & Moore, P. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50122-1 · Cited by 74
Urinary Excretion Rates of Ketamine and Norketamine Following Therapeutic Ketamine Administration: Method and Detection Window Considerations
Adamowicz, P., & Kała, M. (2005) · Journal of Analytical Toxicology · doi:10.1093/jat/29.5.376 · Cited by 73
Narrative Review: Low-Dose Ketamine for Pain Management
Riccardi, A., Guarino, M., Serra, S., Spampinato, M. D., Vanni, S., Shiffer, D., Voza, A., Fabbri, A., & Iaco, F. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093256 · Cited by 79
Increased Response to Ketamine Following Treatment at Long Intervals: Implications for Intermittent Use
Trujillo, K. A., Zamora, J. J., & Warmoth, K. P. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.014 · Cited by 68
Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications
Zhang, M. W., Harris, K. M., & Ho, R. (2016) · BMC Medical Ethics · doi:10.1186/s12910-016-0087-3 · Cited by 67
The Neurobehavioral Pharmacology of Ketamine: Implications for Drug Abuse, Addiction, and Psychiatric Disorders
Trujillo, K. A., Smith, M. L., Sullivan, B., Heller, C. Y., Garcia, C., & Bates, M. L. S. (2011) · ILAR Journal · doi:10.1093/ilar.52.3.366 · Cited by 60
Alcohol and Illicit Drug Use in the Workforce and Workplace
Frone, M. R. (2010) · American Psychological Association eBooks · doi:10.2307/j.ctv1chs29w.20 · Cited by 59
Use and abuse of dissociative and psychedelic drugs in adolescence
Bates, M. L. S., & Trujillo, K. A. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173129 · Cited by 59
Ketamine Psychedelic Psychotherapy: Focus on its Pharmacology, Phenomenology, and Clinical Applications
Kolp, E., Friedman, H. L., Krupitsky, E. M., Jansen, K., Sylvester, M., Young, M. S., & Kolp, A. (2014) · International Journal of Transpersonal Studies · doi:10.24972/ijts.2014.33.2.84 · Cited by 62
Self-citation
Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users
Tervonen, H. E., Tacke, U., & WINSTOCK, A. R. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2014.07.004 · Cited by 54
Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans
Heal, D. J., Gosden, J., & Smith, S. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.049 · Cited by 52
Ketamine and international regulations
Liao, Y., Tang, Y., & Hao, W. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1278449 · Cited by 47
Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances.
Abdulrahim, D., & Bowden‐Jones, O. (2015) · Cited by 46
Overdoses and deaths related to the use of ketamine and its analogues: a systematic review
Chaves, T. V., Wilffert, B., & Sanchez, Z. M. (2022) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2022.2132506 · Cited by 39
Drugs currently in Phase II clinical trials for cocaine addiction
Kim, J. H., & Lawrence, A. J. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.915312 · Cited by 40
Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue—Behavioural, pharmacokinetic and metabolic studies in the Wistar rat
Horsley, R. R., Lhotková, E., Hájková, K., Jurásek, B., Kuchař, M., & Páleníček, T. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.05.002 · Cited by 38
Decreased Thalamocortical Connectivity in Chronic Ketamine Users
Liao, Y., Tang, J., Liu, J., Xie, A., Yang, M., Johnson, M., Wang, X., Deng, Q., Chen, H., Xiang, X., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167381 · Cited by 33
Ketamine sensitization: Influence of dose, environment, social isolation and treatment interval
Trujillo, K. A., & Heller, C. Y. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112271 · Cited by 36
Association of Craving and Depressive Symptoms in Ketamine‐Dependent Patients Undergoing Withdrawal Treatment
Chen, L., Chen, C., Chen, C., Chang, H., Huang, M., & Xu, K. (2020) · The American Journal on Addictions · doi:10.1111/ajad.12978 · Cited by 33
New recreational drugs and the primary care approach to patients who use them
WINSTOCK, A. R., & Mitcheson, L. (2012) · BMJ · doi:10.1136/bmj.e288 · Cited by 32
Uptake of 3,4-methylenedioxymethamphetamine and its related compounds by a proton-coupled transport system in Caco-2 cells
Kuwayama, K., Inoue, H., Kanamori, T., Tsujikawa, K., Miyaguchi, H., Iwata, Y. T., Miyauchi, S., Kamo, N., & Kishi, T. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.023 · Cited by 32
Profiles of Club Drug Users in Treatment
Maxwell, J. C., & Spence, R. T. (2005) · Substance Use & Misuse · doi:10.1081/ja-200066968 · Cited by 31
Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011
Hsu, J., Lin, J.-J., & Tsay, W. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.01.019 · Cited by 30
Reinforcing properties of an intermittent, low dose of ketamine in rats: effects of sex and cycle
Wright, K. N., Strong, C. E., Addonizio, M. N., Brownstein, N. C., & Kabbaj, M. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4470-z · Cited by 30
Characteristics and trends of 3,4-methylenedioxymethamphetamine (MDMA) tablets found in Taiwan from 2002 to February 2005
Teng, S.-F., Wu, S.-C., Liu, C., Li, J., & Chien, C.-S. (2006) · Forensic Science International · doi:10.1016/j.forsciint.2006.03.035 · Cited by 29
Profiling of lllegal Amphetamine-type Stimulant Tablets on Japan.
Makino, Y., Tanaka, S., Kurobane, S., Nakauchi, M., Terasaki, T., & Ohta, S. (2003) · Eisei kagaku · doi:10.1248/jhs.49.129 · Cited by 29
Immunomodulation by cocaine and ketamine in postnatal rats
Rofael, H. Z., Turkall, R. M., & Abdel‐Rahman, M. S. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00081-7 · Cited by 29
Potential benefit of lamotrigine in managing ketamine use disorder
Huang, M., Chen, L., Chen, C., & Lin, S. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.11.011 · Cited by 28
A genosensor based on CPE for study the interaction between ketamine as an anesthesia drug with DNA
Asghary, M., Raoof, J. B., Ojani, R., & Hamidi‐Asl, E. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.07.019 · Cited by 28
The response to club drug use
Maxwell, J. C. (2003) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000069083.26384.03 · Cited by 27
Suicide by hanging under the influence of ketamine and ethanol
Dinis‐Oliveira, R. J., Carvalho, F. D., Duarte, J. A., Dias, R., Magalhães, T., & Santos, A. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2010.04.047 · Cited by 26
N-Methyl-D-Aspartate (NMDA) Antagonists—S(+)-ketamine, Dextrorphan, and Dextromethorphan—Act as Calcium Antagonists on Bovine Cerebral Arteries
Kamel, I. R., Wendling, W. W., Chen, D., Wendling, K. S., HARAKAL, C. D., & Carlsson, C. P. O. (2008) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0b013e31817f523f · Cited by 24
Ketamine as a rapid antidepressant: the debate and implications
Ho, R., & Zhang, M. W. (2016) · BJPsych Advances · doi:10.1192/apt.bp.114.014274 · Cited by 25
The role of ketamine on plasma cocaine pharmacokinetics in rat
Rofael, H. Z., & Abdel‐Rahman, M. S. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(02)00008-5 · Cited by 23
Analysis of amphetamine-type stimulants and their metabolites in plasma, urine and bile by liquid chromatography with a strong cation-exchange column-tandem mass spectrometry
Kuwayama, K., Inoue, H., Kanamori, T., Tsujikawa, K., Miyaguchi, H., Iwata, Y. T., Miyauchi, S., & Kamo, N. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.03.014 · Cited by 23
Reliability, convergent and structural validity and cut-off score of the Severity of Dependence Scale for recreational ketamine users
Fernández‐Calderón, F., Giné, C. V., López-Guerrero, J., & Lozano, O. M. (2016) · Addictive Behaviors · doi:10.1016/j.addbeh.2016.03.016 · Cited by 21
Analgesic effect of perioperative ketamine for total hip arthroplasties and total knee arthroplasties
Wang, P., Yang, Z., Shan, S., Cao, Z., & Wang, Z. (2020) · Medicine · doi:10.1097/md.0000000000022809 · Cited by 20
Sex-Dependent Ketamine Addiction-Like Behavior Profile Following Exposure to Chronic Mild Stress
Wright, K. N., Hagarty, D. P., Strong, C. E., Schoepfer, K. J., & Kabbaj, M. (2019) · Chronic Stress · doi:10.1177/2470547019832613 · Cited by 20
Neuroprotective strategies in drug abuse‐evoked encephalopathy
Virmani, A., Ali, S. F., & BINIENDA, Z. K. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05171.x · Cited by 19
Ketamine beyond anesthesia: Antidepressant effects and abuse potential
Trujillo, K. A., & Iñiguez, S. D. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112841 · Cited by 19
Investigational drug therapies in phase I and phase II clinical trials for alcohol use disorders
Walker, L. C., & Lawrence, A. J. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1502269 · Cited by 19
Safety and efficacy of intranasal ketamine in a mixed population with chronic pain
Carr, D. B., Goudas, L. C., Denman, W. T., Brookoff, D., Lavin, P. T., & Staats, P. S. (2004) · Pain · doi:10.1016/j.pain.2004.04.014 · Cited by 18
The role of NMDARs in the anesthetic and antidepressant effects of ketamine
Zhou, L., & Duan, J. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14464 · Cited by 17
Ketamine—From an Anesthetic to a Psychiatric Drug: Mechanisms of Action, Clinical Applications and Potential Risks
Gibuła‐Tarłowska, E., Wiszniewska, A., Turyk, M., Szymczyk, P., Kotlinska, J. H., & Kędzierska, E. (2025) · Molecules · doi:10.3390/molecules30132824 · Cited by 18
Effect of ketamine pretreatment on cocaine-mediated hepatotoxicity in rats
Rofael, H. Z. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2004.04.035 · Cited by 16
Molecular mechanisms underlying the N-methyl-d-aspartate receptor antagonists: Highlighting their potential for transdiagnostic therapeutics
Driver, C., Jackson, T., Lagopoulos, J., & Hermens, D. F. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110609 · Cited by 17
Long-term administration of ketamine induces erectile dysfunction by decreasing neuronal nitric oxide synthase on cavernous nerve and increasing corporal smooth muscle cell apoptosis in rats
Shang, H., Wu, Y., Liao, C., Chiueh, T., Lin, Y., & Chiang, H. (2016) · Oncotarget · doi:10.18632/oncotarget.10727 · Cited by 16
Ketamine - From medicine to misuse
Wolff, K., & WINSTOCK, A. R. (2006) · Research Portal (King's College London) · Cited by 15
Reliability and validity of the Severity of Dependence Scale in a Chinese sample of treatment-seeking ketamine users.
Tung, C.-K., Yeung, S. W., Chiang, T. P., Xu, K., & Lam, M. W. C. (2014) · PubMed · Cited by 14
Self-Experiments with Psychoactive Substances: A Historical Perspective
Passie, T., & Brandt, S. D. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_177 · Cited by 14
Interactions between 3,4-methylenedioxymethamphetamine, methamphetamine, ketamine, and caffeine in human intestinal Caco-2 cells and in oral administration to rats
Kuwayama, K., Inoue, H., Kanamori, T., Tsujikawa, K., Miyaguchi, H., Iwata, Y. T., Miyauchi, S., Kamo, N., & Kishi, T. (2007) · Forensic Science International · doi:10.1016/j.forsciint.2007.02.034 · Cited by 14
Breaking the drug addiction cycle is not easy in ketamine abusers
Wang, Y., Chen, S., & Lin, C. (2010) · International Journal of Urology · doi:10.1111/j.1442-2042.2010.02491.x · Cited by 14
Mechanism of psychoactive substance-induced cognitive disorders: does tau protein play a role?
Wang, Y., Lv, J., He, J., Wen, G., & Wu, X. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2701006 · Cited by 13
Dissociative Anesthetics
(2008) · CRC Press eBooks · doi:10.1201/9780849378812.ch6 · Cited by 12
Safety in treatment: Classical pharmacotherapeutics and new avenues for addressing maternal depression and anxiety during pregnancy
Dagher, M., Cahill, C. M., & Andrews, A. M. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100046 · Cited by 14
Drogen- und Medikamentenabhängigkeit
Kienast, T., Heinz, A., & Soyka, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_50 · Cited by 11
Analysis of genotoxic activity of ketamine and rocuronium bromide using the somatic mutation and recombination test in Drosophila melanogaster
Koksal, P. M., & Gürbüzel, M. (2014) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2014.12.010 · Cited by 9
Effect of Ketamine on Cocaine-Induced Immunotoxicity in Rats
Rofael, H. Z., Turkall, R. M., & Abdel‐Rahman, M. S. (2003) · International Journal of Toxicology · doi:10.1080/713936677 · Cited by 9
Test-retest reliability and cross-cultural applicability of DSM-5 adopted diagnostic criteria for ketamine use disorders
Fitzgerald, N. D., Striley, C. W., Palamar, J. J., Copeland, J., Kurtz, S. P., & Cottler, L. B. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109056 · Cited by 8
Arylcyclohexamines (Ketamine, Phencyclidine, and Analogues)
Ho, J. H., & Dargan, P. I. (2016) · Springer eBooks · doi:10.1007/978-3-319-20790-2_124-1 · Cited by 8
“K-Powder” Exposure during Adolescence Elicits Psychiatric Disturbances Associated with Oxidative Stress in Female Rats
Cartágenes, S. D. C., da Silveira, C. C. S. D. M., Pinheiro, B. G., Fernandes, L. M. P., Farias, S. V., Kobayashi, N. H. C., de Souza, P. H. F. S., do Prado, A. F., Ferreira, M. K. M., Lima, R. R., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15111373 · Cited by 7
Psychedelika und Dissoziativa in der Psychiatrie: Herausforderungen in der Behandlung
Jungwirth, J., Bavato, F., & Quednow, B. B. (2024) · Der Nervenarzt · doi:10.1007/s00115-024-01727-0 · Cited by 7
Striking Similarities between Clinical and Biological Properties of Ketamine and Ethanol: Linking Antidepressant-After Effect and Burgeoning Addiction?
Scherbaum, U. B. N. (2014) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000198 · Cited by 6
Clinical significance of interleukin‑6 and inducible nitric oxide synthase in ketamine‑induced cystitis
Huang, C., Lee, F., Chen, S., Chien, C., Wu, S., & Wang, Y. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3264 · Cited by 7
Ketamine Abuse: Past and Present
Huang, M., & Lin, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-2902-3_1 · Cited by 8
Ketamina, da anestesia ao uso abusivo
da Silva, F. C. C., Dantas, R. T., Citó, M. D. C. D. O., Vasconcelos, S. M. M., Fonteles, M. M. D. F., Viana, G. S. D. B., & de Sousa, F. C. F. (2001) · Revista Neurociências · doi:10.34024/rnc.2010.v18.8486 · Cited by 7
Clinical pharmacology: other adjuvants
Tziavrangos, E., & Schug, S. A. (2008) · CRC Press eBooks · doi:10.1201/b13460-7 · Cited by 6
Medikamente zur intravenösen Narkoseinduktion: Ketamin, Midazolam und Synopsis der gängigen Hypnotika
Halbeck, E., Dumps, C., & Bolkenius, D. (2018) · Der Anaesthesist · doi:10.1007/s00101-018-0469-7 · Cited by 6
Binge and Subchronic Exposure to Ketamine Promote Memory Impairments and Damages in the Hippocampus and Peripheral Tissues in Rats: Gallic Acid Protective Effects
de Brum, G. F., Rosa, H. Z., Rossato, D. R., da Rosa, J. L. O., Metz, V. G., Milanesi, L. H., & Bürger, M. E. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00215-y · Cited by 6
Ketamina: Nuevas observaciones sobre su consumo, consumidores y efectos
Jansen, K. L. R., & Theron, L. (2003) · Adicciones · doi:10.20882/adicciones.458 · Cited by 6
Self-citation
Effects of Chronic Social Isolation Stress and Alcohol on the Reinforcing Properties of Ketamine in Male and Female Rats
Jennings, S. D., Hagarty, D. P., Logue, J. B., Crawford, M., Saland, S. K., & Kabbaj, M. (2025) · eNeuro · doi:10.1523/eneuro.0452-24.2025 · Cited by 4
Determination of ketamine using melamine-modified gold nanoparticles
GÜNEŞ, G., Can, Z., ARDA, A., & APAK, M. R. (2023) · TURKISH JOURNAL OF CHEMISTRY · doi:10.55730/1300-0527.3593 · Cited by 4
Catatonia and telephone use.
Hillemacher, T., Bleich, S., Demling, J. H., & Kornhuber, J. (2007) · PubMed · Cited by 4
La «keta» (ketamina): del fármaco a la droga de abuso. Clínica biopsicosocial del consumidor y algunas propuestas terapéuticas
Royo-Isach, J., Magrané, M., Domingo, M., & Cortés, B. (2004) · Atención Primaria · doi:10.1016/s0212-6567(04)79486-x · Cited by 4
Ketamine for depressive symptoms: A retrospective chart review of a private ketamine clinic
Juby, V. M., Paruk, S., Tomita, M., & Chiliza, B. (2024) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v30i0.2176 · Cited by 3
Arylcyclohexamines: Ketamine, Phencyclidine, and Analogues
Ho, J. H., & Dargan, P. I. (2017) · Springer eBooks · doi:10.1007/978-3-319-17900-1_124 · Cited by 3
Reduction of Tissue Concentration of Cocaine in Rat by Ketamine
Rofael, H. Z., & Abdel-RahmanHelen, M. (2003) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390306372 · Cited by 3
¿Nuevas drogas de diseño? ¿Nuevas drogas de síntesis?
Claramonte, X., Nogué, S., & Monsalve, C. (2002) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(02)75596-5 · Cited by 3

Authors: Jansen, K. L. R., & Darracot-Cankovic, R.
Affiliations: St Thomas' Hospital (GB)
Venue: Journal of Psychoactive Drugs
Publisher: Informa UK Limited
Published: 2001-06
Volume: 33
Issue: 2
Pages: 151-158
ISSN: 0279-1072 (ISSN-L)
2159-9777
DOI: 10.1080/02791072.2001.10400480
OpenAlex: W2148291000
Cited by: 137
References: 51
Citations by year: 2026: 3 · 2025: 5 · 2024: 4 · 2023: 5 · 2022: 9 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 6 · 2017: 6 · 2016: 11 · 2015: 6 · 2014: 10 · 2013: 1 · 2012: 2
FWCI: 1.21
Type: journal article
Language: en
Open access: closed
Locations: Journal of Psychoactive Drugs (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Keywords: ketamine, ketamine dependence, problematic substance use, craving, tolerance (pharmacology and immunology), withdrawal, harm reduction, psychedelic effects
MeSH terms: Anesthetics, Dissociative, Animals, Drug Tolerance, Humans, Ketamine, Behavior, Addictive, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Nonmedical Use of Ketamlne, Part Two: A Review of Problent Use and Dependence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks